-
Nov 25, 2024 | 
kff.org | Meredith Freed |Tricia Neuman |Juliette Cubanski
NOTE: This analysis was updated in November 2024 to reflect changes in the most recent Physician Fee Schedule Final Rule. Medicare does not offer broad coverage of dental services under traditional Medicare, but through recent regulatory action, the Biden Administration has taken steps to modify Medicare payment policies to expand the types of dental services that are covered.
-
Nov 22, 2024 | 
kff.org | Juliette Cubanski |Anthony Damico
During the Medicare open enrollment period from October 15 to December 7 each year, people with Medicare can enroll in a plan that provides Part D prescription drug coverage, either a stand-alone prescription drug plan (PDP) for people in traditional Medicare, or a Medicare Advantage plan that covers all Medicare benefits, including prescription drugs (MA-PD).
-
Oct 9, 2024 | 
kff.org | Juliette Cubanski
This post was edited on November 15, 2024 to update the number of stand-alone prescription drug plans for 2025, based on updated data on plan availability from the Centers for Medicare & Medicaid Services. CMS’s September 2024 Part D landscape file data initially used for this analysis incorrectly included data for Clear Spring Health PDPs, which were terminated for 2025. Using the October 2024 landscape file produces a lower total plan count and benchmark plan count for 2025.
-
Oct 3, 2024 | 
kff.org | Juliette Cubanski
CMS has just released information about Medicare Part D plans for 2025, including plan availability and premiums for the coming year. While CMS’s headline emphasized stability in terms of average Part D premiums, a quick review of the data shows that many insurers are increasing premiums for their stand-alone drug plan offerings, but not across the board.
-
Sep 24, 2024 | 
theoncologypharmacist.com | William King |Juliette Cubanski |Tricia Neuman |Charlie Dawson
Get TOP in Your Inbox!
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our eNewsletter.
-
Sep 10, 2024 | 
kff.org | Maiss Mohamed |Alice Burns |Juliette Cubanski
This brief was updated on October 24, 2024 to incorporate updates to Medicare and Medicaid administrative data. In 2021, 13 million people under age 65 received income from the Social Security disability programs, Social Security Disability Insurance (SSDI) and Supplemental Security Income (SSI), which provide monthly income to people who are unable to work on account of a disability.
-
Aug 19, 2024 | 
kff.org | Tricia Neuman |Juliette Cubanski |Larry Levitt
Authored by KFF’s Tricia Neuman, Juliette Cubanski and Larry Levitt, this post for Health Affairs Forefront examines how the results of the first-ever Medicare drug price negotiations will generate savings for the government and for Medicare beneficiaries, and how candidates’ views on the issue could play a role in the upcoming elections and in shaping the future of government negotiation of drug prices.
-
Aug 19, 2024 | 
healthaffairs.org | Tricia Neuman |Juliette Cubanski |Larry Levitt
On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) announced negotiated prices for the first 10 drugs selected under Medicare’s new Drug Price Negotiation Program, established by the Inflation Reduction Act of 2022. This announcement marked the end of a months-long negotiation process between CMS and the manufacturers of these 10 drugs, with new prices taking effect for Medicare beneficiaries on January 1, 2026.
-
Aug 1, 2024 | 
kff.org | Juliette Cubanski |Tricia Neuman
The Inflation Reduction Act of 2022 includes several provisions to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government, including several changes to the Part D benefit.
-
Jul 2, 2024 | 
kff.org | Juliette Cubanski |Anthony Damico
The Medicare Part D program provides an outpatient prescription drug benefit to more than 50 million older adults and people with long-term disabilities in Medicare who enroll in private plans, including stand-alone prescription drug plans (PDPs) to supplement traditional Medicare and Medicare Advantage prescription drug plans (MA-PDs) that include drug coverage and other Medicare-covered benefits.
